Karista — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Acticor Biotechacticor-biotech.comin𝕏Feb 2017 · $2M
Acticor Biotech develops Glenzocimab, a therapeutic candidate targeting GPVI for treating acute ischemic stroke and STEMI.
BiotechDigital HealthMedical Devices
Gilles AVENARD(Chief Executive Officer)
Co-investorsNewton BiocapitalAnaxagoGO Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ugloo
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.